DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 156 filers reported holding DIPLOMAT PHARMACY INC in Q4 2015. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $10,000 | -28.6% | 755 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $14,000 | -26.3% | 755 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $19,000 | +5.6% | 755 | -21.4% | 0.00% | 0.0% |
| Q1 2018 | $18,000 | -21.7% | 961 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $23,000 | +27.8% | 961 | +9.8% | 0.00% | 0.0% |
| Q3 2017 | $18,000 | +100.0% | 875 | +53.5% | 0.00% | +100.0% |
| Q2 2017 | $9,000 | +12.5% | 570 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $8,000 | -76.5% | 570 | -53.9% | 0.00% | -75.0% |
| Q4 2016 | $34,000 | 0.0% | 1,236 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $34,000 | -19.0% | 1,236 | +2.7% | 0.00% | -33.3% |
| Q2 2016 | $42,000 | +23.5% | 1,203 | 0.0% | 0.01% | +50.0% |
| Q1 2016 | $34,000 | +78.9% | 1,203 | +113.3% | 0.00% | +33.3% |
| Q4 2015 | $19,000 | +216.7% | 564 | +135.0% | 0.00% | +200.0% |
| Q3 2015 | $6,000 | – | 240 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 7,036,670 | $42,853,000 | 1.54% |
| ARMISTICE CAPITAL, LLC | 3,200,000 | $19,488,000 | 1.23% |
| STEPHENS INC /AR/ | 6,600,015 | $40,194,000 | 0.91% |
| S&T BANK/PA | 610,367 | $3,718,000 | 0.82% |
| Rhenman & Partners Asset Management AB | 1,203,405 | $7,329,000 | 0.81% |
| Matarin Capital Management, LLC | 701,445 | $4,272,000 | 0.30% |
| Investors Research Corp | 89,727 | $546,000 | 0.28% |
| Advisory Services Network, LLC | 598,802 | $3,647,000 | 0.22% |
| FCG ADVISORS, LLC | 34,000 | $207,000 | 0.06% |
| EVERENCE CAPITAL MANAGEMENT INC | 52,730 | $321,000 | 0.05% |